Tyler E. Papp
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- CRISPR and Genetic Engineering
- Viral Infectious Diseases and Gene Expression in Insects
Papers in
-
- RNA Interference and Gene Delivery 8
- Retinal Development and Disorders 3
- CRISPR and Genetic Engineering 3
- Oncology 6
- CAR-T cell therapy research 6
- Co-authors
- Drew Weissman (10 shared papers)Hamideh Parhiz (13 shared papers)Barbara L. Mui (8 shared papers)Ying K. Tam (7 shared papers)Amir Yadegari (7 shared papers)István Tombácz (3 shared papers)Haig Aghajanian (5 shared papers)Steven Μ. Albelda (4 shared papers)
- Journals
- Molecular Therapy (3 papers)Blood (2 papers)Journal of Controlled Release (1 paper)British Journal of Ophthalmology (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United StatesItalyThailand
In The Last Decade
Tyler E. Papp
18 papers receiving 1.4k citations
Tyler E. Papp's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 474
- Molecular Biology 880
- Immunology 244
- Genetics 297
- Cardiology and Cardiovascular Medicine 116
Countries citing papers authored by Tyler E. Papp
This map shows the geographic impact of Tyler E. Papp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler E. Papp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler E. Papp more than expected).
Fields of papers citing papers by Tyler E. Papp
This network shows the impact of papers produced by Tyler E. Papp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler E. Papp. The network helps show where Tyler E. Papp may publish in the future.
Co-authors
The 25 scholars most cited alongside Tyler E. Papp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CAR T Cells Produced in vivo to Treat Cardiac Injury Hit paper breakdown → | 2023 | 655 |
| 2 | Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs Hit paper breakdown → | 2021 | 223 |
| 3 | In vivo hematopoietic stem cell modification by mRNA delivery Hit paper breakdown → | 2023 | 210 |
| 4 | In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism Hit paper breakdown → | 2023 | 143 |
| 5 | 2024 | 32 | |
| 6 | 2024 | 32 | |
| 7 | 2019 | 28 | |
| 8 | 2025 | 17 | |
| 9 | 2019 | 14 | |
| 10 | 2024 | 12 | |
| 11 | 2019 | 10 | |
| 12 | 2018 | 8 | |
| 13 | 2023 | 8 | |
| 14 | 2025 | 3 | |
| 15 | 2025 | 2 | |
| 16 | 2026 | 1 | |
| 17 | 2026 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2026 | 0 |
About Tyler E. Papp
Tyler E. Papp is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Electrical and Electronic Engineering, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), CAR-T cell therapy research (6 papers), Virus-based gene therapy research (5 papers), Retinal Development and Disorders (3 papers), CRISPR and Genetic Engineering (3 papers), Immunotherapy and Immune Responses (2 papers), Advancements in Semiconductor Devices and Circuit Design (2 papers) and Integrated Circuits and Semiconductor Failure Analysis (2 papers). The work is most often cited by research in Oncology (474 citations), Molecular Biology (880 citations), Immunology (244 citations), Genetics (297 citations) and Cardiology and Cardiovascular Medicine (116 citations). Tyler E. Papp has collaborated with scholars based in United States, Italy and Thailand. Frequent co-authors include Drew Weissman, Hamideh Parhiz, Barbara L. Mui, Ying K. Tam, Amir Yadegari, István Tombácz, Haig Aghajanian, Steven Μ. Albelda, Carl H. June and Joel G. Rurik. Their work appears in journals such as Molecular Therapy, Blood, Journal of Controlled Release, British Journal of Ophthalmology and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.